Publications from MSIF and other stakeholders in support of work on access to MS healthcare.
Answers to the most frequently asked questions about our application to add MS treatments to the WHO EML.
MSIF and neurological organisations' statement during the Essential Medicines List Committee open session
Advocating for the addition of MS treatments to the WHO Essential Medicines List
Efforts to improve access to MS treatments continue
MSIF highlights priority actions for MS in the draft global plan